Home
Fulgent Genetics

Fulgent Genetics Market Share Analysis for December 2025

Diseases Targeted: Hereditary Ovarian Cancer Overview: The Ovarian Cancer Focus Panel examines well-established genes associated with an increased risk for hereditary ovarian cancer. Who is this test for? Patients with a personal or family his...

Health > Health Conditions and Concerns

Domainfulgentgenetics.com

Year Founded2011

Employees201 - 500

Annual Revenue> $1B

Fulgent Genetics

Showing Fulgent Genetics's traffic and engagement information for its main website (including company regionals)

fulgentgenetics.com
informdx.com
csilaboratories.com

See more website traffic and engagement information

Fulgent Genetics Revenue up to December 2025 is > 1B

revenue generated by Fulgent Genetics top domains

Fulgent Genetics top domains revenue over 3 years

Revenue for Fulgent Genetics top domains

fulgentgenetics.com> 1B

informdx.com100M - 200M

csilaboratories.com10M - 15M

See more with Sales Intelligence

Total visits to Fulgent Genetics's top domains

Understand Fulgent Genetics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

fulgentgenetics.com36.3K

informdx.com5.4K

csilaboratories.com2K

See more with Sales Intelligence

Avg. visit duration in Fulgent Genetics's top domains

Analyze Fulgent Genetics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

fulgentgenetics.com00:00:43

informdx.com00:02:36

csilaboratories.com00:00:42

See more with Sales Intelligence

Avg. pageviews on Fulgent Genetics's top domains

See how Fulgent Genetics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

fulgentgenetics.com1.58

informdx.com4.96

csilaboratories.com2.43

See more with Sales Intelligence

Fulgent Genetics top competitors by domain

Top similar sites in December 2025, ranked by their affinity

preventiongenetics.comCompany NamePreventionGeneticsEmployees51 - 200HQUnited States, Wisconsin, MarshfieldAnnual revenue$25M - $50MTotal visits29.4KHealth > Health Conditions and Concerns

Top technologies used by Fulgent Genetics

These are the website technologies, by industry, used by Fulgent Genetics top domains

Payment & Currencies (7)

Cart Functionality

Advertising (4)

DoubleClick

Email Services (4)

G Suite

Content Management System (2)

Atlassian Cloud

More Technologies

13

See all

News & Signals from Fulgent Genetics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFulgent Genetics, Inc. acquired StrataDx - Strata Pathology Services Inc. on Dec 22nd '25.Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US-based laboratories, for a combined purchase price of around $55.5m.

NewsStrataDx - Strata Pathology Services Inc. sells assets to Fulgent Genetics, Inc. in the amount of $55.5M.Fulgent Genetics to acquire select assets of Bako Diagnostics and StrataDx for $55.5m.

NewsFulgent Genetics, Inc. acquires Bakodx.Latham & Watkins advises on fulgent Genetics' acquisition of Bako Diagnostics and stratadx.